Syk tyrosine kinase inhibitors (Boehringer Ingelheim/3-DP)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSyk tyrosine kinase inhibitors (Boehringer Ingelheim/3-DP)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies3-Dimensional Pharmaceuticals IncBoehringer Ingelheim Corp
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A